Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,476,154
+$1,345,187 QoQ
Shares Held
13,814
+41.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#1,547
of 4,153 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Goldstone Financial Group, LLC holds $6,133,464 across 6 Drug Manufacturers - General names. ABBV ranks #1 (56.7% of the industry book) .
All Filings in ABBV
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,476,154 | 13,814 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,130,967 | 9,798 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,067,834 | 9,050 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,061,169 | 8,902 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,644,407 | 8,859 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $2,751,626 | 13,133 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $1,561,272 | 8,786 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,727,752 | 8,749 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,516,408 | 8,841 | Shares | Sole | 2025-01-15 | |
| 2024-03-31 | $1,439,318 | 7,904 | Shares | Sole | 2025-01-15 | |
| 2023-12-31 | $1,233,561 | 7,960 | Shares | Sole | 2025-01-15 | |
| 2023-09-30 | $1,182,492 | 7,933 | Shares | Sole | 2025-01-15 | |
| 2023-06-30 | $1,079,456 | 8,012 | Shares | Sole | 2025-01-15 | |
| 2023-03-31 | $1,406,121 | 8,823 | Shares | Sole | 2025-01-15 | |
| No filing history on record for this holder in this stock. | ||||||